| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |